<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000046158">
  <TermName>thrombopoietin</TermName>
  <TermPronunciation>(THROM-boh-POY-eh-tin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance made by the body that helps make blood cells, especially platelets. A form of thrombopoietin made in the laboratory is called recombinant human thrombopoietin and rHu thrombopoietin. Thrombopoietin is being studied as a way to increase the number of platelets in cancer patients receiving chemotherapy. Also called TPO.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000707760" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;thrombopoietin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000707761" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;trombopoyetina&quot;" language="es" id="_4"/>
  <SpanishTermName>trombopoyetina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia elaborada por el cuerpo que ayuda a producir células sanguíneas, especialmente plaquetas. Una forma de trombopoyetina que se produce en el laboratorio se llama trombopoyetina humana recombinante y trombopoyetina rHu. Asimismo, la trombopoyetina está en estudio como forma de aumentar el número de plaquetas de los pacientes de cáncer que reciben quimioterapia. También se llama TPO.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2008-01-22</DateLastModified>
</GlossaryTerm>
